✦ LIBER ✦

Development of [90Y]DOTA-conjugated bisphosphonate for treatment of painful bone metastases

✍ Scribed by Kazuma Ogawa; Hidekazu Kawashima; Kazuhiro Shiba; Kohshin Washiyama; Mitsuyoshi Yoshimoto; Yasushi Kiyono; Masashi Ueda; Hirofumi Mori; Hideo Saji

Book ID: 116799286
Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 178 KB
Volume: 36
Category: Article
ISSN: 0969-8051
DOI: 10.1016/j.nucmedbio.2008.11.007

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Treatment of Bone Metastases and Bone Pa

Treatment of Bone Metastases and Bone Pain with Bisphosphonates

✍ Lipton, Allan 📂 Article 📅 2007 🏛 CIG Media Group, LP. 🌐 English ⚖ 146 KB

Bisphosphonates in the treatment of pain

Bisphosphonates in the treatment of pain from bone metastases

✍ Gottlieb, A.; Luzzani, M.; Nicosia, F.; Nobile, M.T.; Rissotto, R.; Zappi, L. 📂 Article 📅 1990 🏛 Elsevier Science 🌐 English ⚖ 101 KB

Usefulness of competitive inhibitors of

Usefulness of competitive inhibitors of protein binding for improving the pharmacokinetics of186Re-MAG3-conjugated bisphosphonate (186Re-MAG3-HBP), an agent for treatment of painful bone metastases

✍ Kazuma Ogawa; Takahiro Mukai; Keiichi Kawai; Norito Takamura; Hirofumi Hanaoka; 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 163 KB

Comparison of Yttrium and Indium Complex

Comparison of Yttrium and Indium Complexes of DOTA-BA and DOTA-MBA: Models for 90 Y- and 111 In-Labeled DOTA−Biomolecule Conjugates

✍ Liu, Shuang; Pietryka, John; Ellars, Charles E.; Edwards, D. Scott 📂 Article 📅 2002 🏛 American Chemical Society 🌐 English ⚖ 222 KB

Design of a radiopharmaceutical for the

Design of a radiopharmaceutical for the palliation of painful bone metastases: rhenium-186-labeled bisphosphonate derivative

✍ Kazuma Ogawa; Takahiro Mukai; Yasushi Arano; Hirofumi Hanaoka; Kazuyuki Hashimot 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 French ⚖ 123 KB

## Abstract To develop a radiopharmaceutical for the palliation of painful bone metastases based on the concept of bifunctional radiopharmaceuticals, we designed a bisphosphonate derivative attached to a stable ^186^Re‐monoaminemonoamidedithiol (MAMA) chelate (^186^Re‐MAMA‐BP) to improve the instab

Patient-reported outcome instruments use

Patient-reported outcome instruments used to assess pain and functioning in studies of bisphosphonate treatment for bone metastases

✍ Louis S. Matza; Lesley J. Fallowfield; Karen C. Chung; Brooke M. Currie; Kate Va 📂 Article 📅 2012 🏛 Springer-Verlag 🌐 English ⚖ 325 KB